The Filing Desk

Delcath Systems vs TELA Bio

Delcath Systems DCTH · TELA Bio TELA · Health Care Equipment

Delcath Systems reported revenue of $85 million in fiscal 2025, about the same as TELA Bio's $80 million in fiscal 2025. Delcath Systems' revenue grew 129.1% in its latest year, and TELA Bio's grew 15.8%. Delcath Systems had an operating margin of 0.8%, against -42.0% at TELA Bio. Free cash flow was $21 million at Delcath Systems and −$29 million at TELA Bio.

Side by side

Delcath SystemsTELA Bio
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$85M$80M
Revenue growth129.1%15.8%
Revenue growth a year, last 5 years—34.6%
Gross margin86.2%67.7%
Operating margin0.8%−42.0%
Net margin3.2%−48.4%
Free cash flow$21M−$29M
Free cash flow margin24.6%−35.7%
Return on capital2.8%−190.2%
Net debt to EBITDA−101.4x—
Dividends and buybacks$6M$0M
Change in diluted share count40.0%64.6%
Last close$19.24$0.73
P/E at the last close120.2×—
Insider trades, last 12 monthsbought $189,362, sold $0bought $186,250, sold $0
Piotroski F-score6 of 94 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Delcath SystemsTELA Bio
Operating margin
Percent of revenue
Delcath SystemsTELA Bio
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Delcath SystemsTELA Bio

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Delcath Systems and TELA Bio pages.